Jack P. Shonkoff, M.D.
Julius B. Richmond FAMRI Professor of Child Health and Development
Director, Center on the Developing Child
Professor of Pediatrics, HMS and Boston Children's Hospital
Degree: M.D., New York University, (1972)
Office: 50 Church Street 4th Floor
Office Hours Contact: Email the Faculty Member
Faculty Assistant: Yaimani Rivera
Jack Shonkoff, M.D., is the Julius B. Richmond FAMRI Professor of Child Health and Development at the Harvard T.H. Chan School of Public Health and the Harvard Graduate School of Education; professor of pediatrics at Harvard Medical School and Boston Children's Hospital; and director of the Center on the Developing Child at Harvard University. He currently serves as chair of the National Scientific Council on the Developing Child, a group whose mission is to bring credible science to bear on public policy affecting young children, and chairs the JPB Research Network on Toxic Stress. In 2011, Shonkoff launched Frontiers of Innovation, a multi-sectoral collaboration among researchers, practitioners, policymakers, investors, and experts in systems change who are committed to developing more effective intervention strategies to catalyze breakthrough impacts on the development and health of young children and families experiencing significant adversity.
Under the auspices of the National Academy of Sciences, Shonkoff served as chair of the Board on Children, Youth, and Families and the committee that produced the landmark report, From Neurons to Neighborhoods: The Science of Early Childhood Development. He also served as a member of the Panel on Child Care Policy, the Committee on the Assessment of Family Violence Interventions, and the Roundtable on Head Start Research.
Shonkoff's honors include being elected to the Institute of Medicine of the National Academy of Sciences and the American Pediatric Society; being designated National Associate of the National Academies; and receiving the C. Anderson Aldrich Award in Child Development from the American Academy of Pediatrics and the Award for Distinguished Contributions to Public Policy for Children from the Society for Research in Child Development.
Shonkoff has served on the core scientific group of the MacArthur Research Network on Early Experience and Brain Development, the Governing Council of the Society for Research in Child Development, and the Executive Committee of the Section on Developmental and Behavioral Pediatrics of the American Academy of Pediatrics. He has authored more than 150 publications, including nine books; co-edited two editions of the Handbook of Early Childhood Intervention; and served on the editorial board of several scholarly journals, including Child Development.
Shonkoff completed his undergraduate studies at Cornell, medical education at NYU School of Medicine, pediatric training at Bronx Municipal Hospital Center and the Albert Einstein College of Medicine, and fellowship in developmental pediatrics at Harvard Medical School and Boston Children's Hospital. He has been a visiting professor or delivered named lectureships at universities in the U.S., Australia, Brazil, Canada, China, Israel, Japan, Mexico, Puerto Rico, Turkey, and the U.K. He was the Samuel F. and Rose B. Gingold Professor of Human Development and Social Policy and dean of The Heller School for Social Policy and Management at Brandeis University.
Click here to see a full list of Jack Shonkoffs courses.
Continuing the Djokovic Science and Innovation Fellowship Program (2019-2021)
Novak Djokovic Foundation
The aim of the Djokovic Science and Innovation Fellowship is to develop this next generation of academic change agents who will both contribute to advances in science and leverage those advances to inform, inspire, and mobilize key actors in the field of early childhood towards new solutions that yield breakthrough outcomes for children facing adversity. As such, Djokovic Fellows will receive rigorous training in translational research, framing and communications, and science-based innovation. In addition, the Djokovic Fellows will be able to draw on the Center on the Developing Child's many resources to deepen their own scholarly interests and advance their scholarly pursuits. While the program experience will be tailored to each Fellow's research interests and professional development it will universally include:1. Learning about the Center's IDEAS Impact Framework (IDEAS)2. Learning about the Center's knowledge synthesis, translation, and communications work and strategies3. Learning about the Center's approach to science-based innovation in policy and practice systems
Supporting Mobilization of Science Based Innovation (2018-2020)
grant is in support of the CenterÂ’s vision of science-based innovation as a catalyst for change as outlined in our newly completed business plan, in which all major efforts are aligned to leverage our CenterÂ’s unique science engine to drive 2 strategic initiatives: (1) building an innovation pipeline within the early childhood ecosystem; and (2) creating a pediatric innovation cluster linked to that pipeline. Our science engine consists of 3 highly inter-related components: (1) science synthesis, translation & communication; (2) a more precise approach to intervention design, evaluation & strengthening; and (3) new measures of stress effects and resilience.
The JPB Research Network on Toxic Stress (2018-2021)
The foundations of healthy development are built early in life, yet significant adversity can disrupt developing brain architecture and other biological systems leading to physiological changes and behaviors that increase risk for lifelong problems in development, achievement, and both physical and mental health. Reducing stresses on families, strengthening parent-child relationships, and building the adult skills needed to provide a well-regulated caregiving environment all offer promising pathways toward better life outcomes for millions of children living under adverse conditions. Pediatric primary care, which provides the earliest possible access to the largest percentage of young children, especially those at greatest risk, is a key delivery channel for developing, testing, and ultimately implementing such strategies. Achieving greater impacts in the context of primary health care requires a better understanding of two critical challenges: (1) variation in susceptibility to adversity (in order to direct finite resources to those at greatest risk) and (2) individual differences in response to intervention (to match targeted services to the varied assets and needs of children and families).The ultimate goal of The JPB Research Network on Toxic Stress is to leverage 21st-century science to transform pediatric practice and produce breakthrough impacts at scale on the lives of millions of children and families facing adversity. Our strategy for achieving this goal is to fundamentally change the way we understand, measure, and reduce or mitigate the effects of excessive, early stress on child development and lifelong health. Our aim is to strengthen the capacity of the primary care system to promote both physical and mental well-being for each individual child by adopting a scientifically-grounded approach to two key challenges: (1) providing more effective guidance and support for parents raising young children under a variety of conditions; and(2) catalyzing a segmentation approach to developing, strengthening, and evaluating intervention strategies that enables us to learn what works for whom, why, and in what context in order to personalize services for children and families. The development of a validated measure of stress effects in young children is a critical prerequisite for addressing these challenges. The successes of the NetworkÂ’s initial three-year period are reflected in both the novel, candidate, biomarker battery that has been designed specifically for young children, and the authentic co-ownership of this effort by a deeply committed group of scientists, practitioners, and community leaders. The current battery includes adaptations of advances in the biological sciences (e.g., assays of oxidative stress at the cellular level) and several newly created indicators for childhood populations, including a pediatric epigenetic Â“clockÂ” defining atypical development, polygenic risk scores, and measures of altered brain development and metabolic trajectories, all linked in human and animal models. These accomplishments demonstrate the integrative capacity of the Network and its potential ability to expand the application of rapidly spreading principles of Â“precision medicineÂ” beyond the treatment of illness to the promotion of health and prevention of disease. In the proposed work plan for Phase II, Network scientists will continue to dig deeper into the biology of adversity, resilience, and developmental plasticity to assure that the biomarker battery is informed by cutting-edge science.